Invention Publication
- Patent Title: HETEROCYCLIC COMPOUND
-
Application No.: US18497602Application Date: 2023-10-30
-
Publication No.: US20240174677A1Publication Date: 2024-05-30
- Inventor: Yasushi HATTORI , Marilena PIRA , Yoshiteru ITO , Kohei TAKEUCHI , Eiji KIMURA , Norihito TOKUNAGA , Shuhei IKEDA , Martin Alexander PAWLICZEK , Noriyuki TEZUKA , Yasutaka HOASHI , Yuhei MIYANOHANA , Yuichi KAJITA , Tatsuki KOIKE
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P25/00 ; C07D413/04 ; C07D519/00
Abstract:
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.
A compound represented by the formula (I):
wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
A compound represented by the formula (I):
wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
Public/Granted literature
- US11987586B1 Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists Public/Granted day:2024-05-21
Information query
